Crescita Therapeutics Inc

TSX:CTX (Canada)  
C$ 0.58 (-3.33%) Nov 30
At Loss
P/B:
0.70
Market Cap:
C$ 11.09M ($ 7.91M)
Enterprise V:
C$ 3.58M ($ 2.55M)
Volume:
14.29K
Avg Vol (2M):
31.13K
Warning! GuruFocus detected 2 Severe warning signs with CTX. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
14.29K
Market Cap C$:
11.09M
Market Cap $:
7.91M
At Loss
Avg Vol (2M):
31.13K
Enterprise Value C$:
3.58M
Enterprise Value $:
2.55M
PB Ratio:
0.70
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Crescita Therapeutics Inc
NAICS : 325412 SIC : 3741
ISIN : CA2258471028
https://www.crescitatherapeutics.com
2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3
Compare
Compare
XCNQ:XTRXTSX:VPHXCNQ:CANNTSX:XLYTSXV:MPHXCNQ:RVVXCNQ:BAMMTSX:WLLWXCNQ:SLNGNEOE:TILTZTSXTER:MRKTSE:4502LSE:HLNNSE:SUNPHARMATSE:4523TSE:4507SZSE:000538XSWX:SDZHKSE:03692
Traded in other countries / regions
CTX.CanadaCRRTF.USA
IPO Date
2016-03-07
Description
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt 9.11
Equity-to-Asset 0.71
Debt-to-Equity 0.06
Debt-to-EBITDA -1.09
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.83
Distress
Grey
Safe
Beneish M-Score -3.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

4/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 5.1
3-Year EBITDA Growth Rate -69.7
3-Year FCF Growth Rate -28.7
3-Year Book Growth Rate -2.7

Momentum Rank

6/10
Name Current Vs Industry Vs History
5-Day RSI 31.63
9-Day RSI 41.83
14-Day RSI 45.25
6-1 Month Momentum % 42.86
12-1 Month Momentum % 55.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.7
Quick Ratio 1.68
Cash Ratio 1.4
Days Inventory 268.88
Days Sales Outstanding 43.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.1
Shareholder Yield % 5.54

Profitability Rank

5/10
Name Current Vs Industry Vs History
Gross Margin % 55.58
Operating Margin % -17.58
Net Margin % -15.73
FCF Margin % -3.77
ROE % -15.32
ROA % -11.44
ROIC % -33.32
ROC (Joel Greenblatt) % -48.02
ROCE % -13.23
Years of Profitability over Past 10-Year 4

GF Value Rank

Name Current Vs Industry Vs History
Price-to-Owner-Earnings 96.67
PS Ratio 0.65
PB Ratio 0.7
Price-to-Tangible-Book 0.78
Price-to-Operating-Cash-Flow 10.35
EV-to-EBIT -1.45
EV-to-EBITDA -4.21
EV-to-Revenue 0.21
EV-to-FCF -5.45
Price-to-Projected-FCF 0.42
Price-to-Net-Current-Asset-Value 1.16
Price-to-Net-Cash 6.44
Earnings Yield (Greenblatt) % -68.97
FCF Yield % -5.92

Financials

TSX:CTX's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Crescita Therapeutics Inc Executives

Details

GF Value: C$0.56

TSX:CTX

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 17.403
EPS (TTM) (C$) -0.14
Beta 0.65
Volatility % 46.41
14-Day RSI 45.25
14-Day ATR (C$) 0.016499
20-Day SMA (C$) 0.592
12-1 Month Momentum % 55.84
52-Week Range (C$) 0.36 - 0.69
Shares Outstanding (Mil) 19.12

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Crescita Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Crescita Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Crescita Therapeutics Inc Frequently Asked Questions

What is Crescita Therapeutics Inc(TSX:CTX)'s stock price today?
The current price of TSX:CTX is C$0.58. The 52 week high of TSX:CTX is C$0.69 and 52 week low is C$0.36.
When is next earnings date of Crescita Therapeutics Inc(TSX:CTX)?
The next earnings date of Crescita Therapeutics Inc(TSX:CTX) is .
Does Crescita Therapeutics Inc(TSX:CTX) pay dividends? If so, how much?
Crescita Therapeutics Inc(TSX:CTX) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.